Weybosset Research & Management LLC Abb Vie Inc. Transaction History

Weybosset Research & Management LLC

$267 Million
Q2 2024

A detailed history of Weybosset Research & Management LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Weybosset Research & Management LLC holds 1,505 shares of ABBV stock, worth $261,283. This represents 0.1% of its overall portfolio holdings.

Number of Shares

1,505

Previous 1,455 3.44%

Holding current value

$261,283

Previous $673,000 61.66%

% of portfolio

0.1%

Previous 0.23%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 22, 2024	BUY	$154.79 - $180.76 $7,739 - $9,038	50 Added 3.44%	1,505 $258,000
Q1 2024 Apr 22, 2024	SELL	$159.82 - $182.1 $39,955 - $45,525	-250 Reduced 14.66%	1,455 $673,000
Q4 2023 Jan 18, 2024	BUY	$137.6 - $154.97 $13,760 - $15,497	100 Added 6.23%	1,705 $264,000
Q2 2023 Jul 12, 2023	SELL	$132.51 - $164.9 $217,978 - $271,260	-1,645 Reduced 50.62%	1,605 $216,000
Q1 2023 Apr 14, 2023	SELL	$144.61 - $166.54 $28,922 - $33,308	-200 Reduced 5.8%	3,250 $518,000

Q4 2022 Feb 16, 2023	BUY	$138.31 - $165.87 $27,662 - $33,174	200 Added 6.15%	3,450 $558,000
Q3 2022 Nov 07, 2022	BUY	$134.21 - $153.93 $67,105 - $76,965	500 Added 18.18%	3,250 $436,000
Q2 2022 Aug 08, 2022	BUY	$137.62 - $174.96 $378,455 - $481,140	2,750 New	2,750 $201,000
Q4 2021 Jan 19, 2022	SELL	$107.43 - $135.93 $214,860 - $271,860	-2,000 Closed	0 $0
Q3 2021 Oct 25, 2021	SELL	$106.4 - $120.78 $138,320 - $157,014	-1,300 Reduced 39.39%	2,000 $216,000
Q2 2021 Jul 26, 2021	BUY	$105.21 - $117.21 $21,042 - $23,442	200 Added 6.45%	3,300 $372,000
Q4 2020 Jan 21, 2021	SELL	$80.49 - $108.67 $24,147 - $32,601	-300 Reduced 8.82%	3,100 $332,000
Q3 2020 Oct 28, 2020	SELL	$85.91 - $100.83 $90,205 - $105,871	-1,050 Reduced 23.6%	3,400 $298,000
Q4 2019 Jan 27, 2020	BUY	$72.13 - $90.25 $320,978 - $401,612	4,450 New	4,450 $394,000
Q3 2019 Oct 22, 2019	SELL	$62.98 - $75.72 $280,261 - $336,954	-4,450 Closed	0 $0
Q1 2019 Apr 15, 2019	SELL	$77.14 - $90.79 $19,285 - $22,697	-250 Reduced 5.32%	4,450 $3.59 Million
Q4 2018 Jan 25, 2019	BUY	$77.85 - $96.01 $365,895 - $451,247	4,700 New	4,700 $433,000
Q3 2018 Oct 11, 2018	SELL	$88.91 - $98.84 $326,744 - $363,237	-3,675 Closed	0 $0
Q1 2018 May 02, 2018	SELL	$92.01 - $123.21 $41,404 - $55,444	-450 Reduced 10.91%	3,675 $348,000
Q4 2017 Feb 05, 2018	SELL	$89.56 - $98.21 $42,541 - $46,649	-475 Reduced 10.33%	4,125 $399,000
Q3 2017 Oct 23, 2017	BUY	$69.85 - $89.22 $321,310 - $410,412	4,600	4,600 $409,000

Others Institutions Holding ABBV

# of Institutions

3,653

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.5M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $307B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Weybosset Research & Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Weybosset Research & Management LLC with notifications on news.

Account

Weybosset Research & Management LLC Abb Vie Inc. Transaction History